Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR.

about

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR.

Item

http://www.wikidata.org/entity/Q49404597

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@en

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@nl

type

Item

label

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@en

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@nl

prefLabel

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@en

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@nl

P1476

Metastatic Recurrence of Typic ...... y Treated with Octreotide LAR.

@en

P2093

Asako Yanagisawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Tabeta

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Amano

http://www.w3.org/2001/XMLSchema#string

Kohei Shikano

http://www.w3.org/2001/XMLSchema#string

Makoto Nakamura

http://www.w3.org/2001/XMLSchema#string

Noriko Hayama

http://www.w3.org/2001/XMLSchema#string

Shinichiro Shimizu

http://www.w3.org/2001/XMLSchema#string

Sukeyuki Nakamura

http://www.w3.org/2001/XMLSchema#string

Takuma Hiroishi

http://www.w3.org/2001/XMLSchema#string

Tetsuo Fujita

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.

Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.

Cancer: antitumor effects of octreotide LAR, a somatostatin analog.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.

P304

1564819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2017/1564819

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Satoshi Hirano

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29445555

http://www.w3.org/2001/XMLSchema#string

P932

5763055

http://www.w3.org/2001/XMLSchema#string